AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 64(3), 2001, pp. 147-153
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darwish, M.
Right arrow Articles by Clemens, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darwish, M.
Right arrow Articles by Clemens, J.
Related Collections
Right arrow Epidemiology
Right arrow Hepatitis
American Journal of Tropical Medicine and Hygiene, Vol 64, Issue 3, 147-153
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study

MA Darwish, R Faris, N Darwish, A Shouman, M Gadallah, MS El-Sharkawy, R Edelman, K Grumbach, MR Rao, and JD Clemens

Residents of Egypt's Nile river delta have among the world's highest seroprevalence of hepatitis C virus (HCV) infection. To assess the impact of HCV on chronic liver disease, we studied the association between HCV, other hepatitis viruses, and cirrhotic liver disease in a cross-sectional, community-based survey of 801 persons aged > or = 10 years living in a semi-urban, Nile delta village. Residents were systematically sampled using questionnaires, physical examination, abdominal ultrasonography and serologically for antibodies to HCV (confirmed by a third-generation immunoblot assay) and to hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis E virus (HEV). The seroprevalence of HCV increased with age from 19% in persons 10-19 years old to about 60% in persons 30 years and older. Although no practices that might facilitate HCV transmission were discovered, the seroprevalence of HCV was significantly associated with remote (> 1 year) histories of schistosomiasis. Sonographic evidence of cirrhosis was present in 3% (95% CI: 1%, 4%) of the population (0.7% of persons under 30 years of age and in 5% of older persons), and was significantly associated with HCV seroreactivity. Our findings are consistent with the hypothesis that past mass parenteral chemotherapy campaigns for schistosomiasis facilitated HCV transmission, and that HCV may be a major cause of the high prevalence of liver cirrhosis in this Nile village.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
M. K. MOHAMED, L. S. MAGDER, M. ABDEL-HAMID, M. EL-DALY, N. N. MIKHAIL, F. ABDEL-AZIZ, A. MEDHAT, V. THIERS, and G. T. STRICKLAND
TRANSMISSION OF HEPATITIS C VIRUS BETWEEN PARENTS AND CHILDREN.
Am J Trop Med Hyg, July 1, 2006; 75(1): 16 - 20.
[Abstract] [Full Text] [PDF]

Home page
 HEALTH PROMOT INTHome page
M. Kermode
Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses
Health Promot. Int., March 1, 2004; 19(1): 95 - 103.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.